Clinical Trials for Dracen Pharmaceuticals

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Dracen Pharmaceuticals

Clinical Trials (1)

NCT06027086
DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
PHASE1/PHASE2Recruiting
27 participants
Started: Feb 12, 2024 · Completed: Sep 1, 2033
1 condition3 sponsors1 location